Hepatocellular Carcinoma: From Diagnosis to Treatment

Overview

Journal World J Hepatol

Publisher Baishideng Publishing Group

Specialty Gastroenterology

Date 2015 Jun 9

PMID 26052391

Citations 67

Authors

Abhijeet Waghray

Arvind R Murali

Kv Narayanan Menon

Affiliations

Soon will be listed here.

Abstract

Hepatocellular carcinoma (HCC) is the sixth most prevalent malignancy worldwide and is a rising cause of cancer related mortality. Risk factors for HCC are well documented and effective surveillance and early diagnosis allow for curative therapies. The majority of HCC appears to be caused by cirrhosis from chronic hepatitis B and hepatitis C virus. Preventive strategies include vaccination programs and anti-viral treatments. Surveillance with ultrasonography detects early stage disease and improves survival rates. Many treatment options exist for individuals with HCC and are determined by stage of presentation. Liver transplantation is offered to patients who are within the Milan criteria and are not candidates for hepatic resection. In patients with advanced stage disease, sorafenib shows some survival benefit.

Citing Articles

Direct-acting antivirals sofosbuvir and daclatasvir attenuate carbon tetrachloride-induced liver fibrosis in mice.

Abdelsalam M, El-Mahdy N, Abou-Saif S Liver Res. 2025; 7(1):71-81.

PMID: 39959700 PMC: 11791913. DOI: 10.1016/j.livres.2023.02.001.

Comparison of Radiofrequency Ablation and Microwave Ablation for the Management of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Shaqran T, Alharbi J, Al-Hunbusi S, Alharbi R, Alawaji M, Diqarshawi A Cureus. 2024; 16(8):e67938.

PMID: 39328664 PMC: 11426338. DOI: 10.7759/cureus.67938.

STEAP2 promotes hepatocellular carcinoma progression via increased copper levels and stress-activated MAP kinase activity.

Torrez C, Easley A, Bouamar H, Zheng G, Gu X, Yang J Sci Rep. 2024; 14(1):12753.

PMID: 38830975 PMC: 11148201. DOI: 10.1038/s41598-024-63368-2.

Non-contrast short MRI surveillance for HCC screening: the study protocol of the SMS-HCC prospective multicenter study.

de Braak C, Willemssen F, de Man R, van der Lugt A, Uyl-de Groot C, Bos D Eur Radiol Exp. 2024; 8(1):29.

PMID: 38467990 PMC: 10928023. DOI: 10.1186/s41747-024-00432-6.

Mutational Landscape and Precision Medicine in Hepatocellular Carcinoma.

Gorji L, Brown Z, Pawlik T Cancers (Basel). 2023; 15(17).

PMID: 37686496 PMC: 10487145. DOI: 10.3390/cancers15174221.

References

Rosenblatt K, Weiss N, Schwartz S . Liver cancer in Asian migrants to the United States and their descendants. Cancer Causes Control. 1996; 7(3):345-50. DOI: 10.1007/BF00052940. View

Lai C, Yuen M . Prevention of hepatitis B virus-related hepatocellular carcinoma with antiviral therapy. Hepatology. 2012; 57(1):399-408. DOI: 10.1002/hep.25937. View

Cho Y, Kim J, Kim M, Rhim H, Han J . Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies. Hepatology. 2008; 49(2):453-9. DOI: 10.1002/hep.22648. View

Bruix J, Sherman M . Management of hepatocellular carcinoma: an update. Hepatology. 2011; 53(3):1020-2. PMC: 3084991. DOI: 10.1002/hep.24199. View

Leung J, Zhu A, Gordon F, Pratt D, Mithoefer A, Garrigan K . Liver transplantation outcomes for early-stage hepatocellular carcinoma: results of a multicenter study. Liver Transpl. 2004; 10(11):1343-54. DOI: 10.1002/lt.20311. View

Teh S, Christein J, Donohue J, Que F, Kendrick M, Farnell M . Hepatic resection of hepatocellular carcinoma in patients with cirrhosis: Model of End-Stage Liver Disease (MELD) score predicts perioperative mortality. J Gastrointest Surg. 2005; 9(9):1207-15. DOI: 10.1016/j.gassur.2005.09.008. View

Brechot C, Pourcel C, Louise A, Rain B, Tiollais P . Presence of integrated hepatitis B virus DNA sequences in cellular DNA of human hepatocellular carcinoma. Nature. 1980; 286(5772):533-5. DOI: 10.1038/286533a0. View

Forner A, Vilana R, Ayuso C, Bianchi L, Sole M, Ayuso J . Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. Hepatology. 2007; 47(1):97-104. DOI: 10.1002/hep.21966. View

ALPERT M, Uriel J, de Nechaud B . Alpha-1 fetoglobulin in the diagnosis of human hepatoma. N Engl J Med. 1968; 278(18):984-6. DOI: 10.1056/NEJM196805022781804. View

10.

Calle E, Rodriguez C, Walker-Thurmond K, Thun M . Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003; 348(17):1625-38. DOI: 10.1056/NEJMoa021423. View

11.

Curley S . Radiofrequency ablation of malignant liver tumors. Oncologist. 2001; 6(1):14-23. DOI: 10.1634/theoncologist.6-1-14. View

12.

Vogl T, Lammer J, Lencioni R, Malagari K, Watkinson A, Pilleul F . Liver, gastrointestinal, and cardiac toxicity in intermediate hepatocellular carcinoma treated with PRECISION TACE with drug-eluting beads: results from the PRECISION V randomized trial. AJR Am J Roentgenol. 2011; 197(4):W562-70. DOI: 10.2214/AJR.10.4379. View

13.

Llovet J, Schwartz M, Mazzaferro V . Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis. 2005; 25(2):181-200. DOI: 10.1055/s-2005-871198. View

14.

Llovet J, Bru C, Bruix J . Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis. 1999; 19(3):329-38. DOI: 10.1055/s-2007-1007122. View

15.

Ikeda K, Saitoh S, Koida I, Arase Y, Tsubota A, Chayama K . A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology. 1993; 18(1):47-53. View

16.

Schwartz M, Roayaie S, Konstadoulakis M . Strategies for the management of hepatocellular carcinoma. Nat Clin Pract Oncol. 2007; 4(7):424-32. DOI: 10.1038/ncponc0844. View

17.

Salem R, Lewandowski R, Kulik L, Wang E, Riaz A, Ryu R . Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma. Gastroenterology. 2010; 140(2):497-507.e2. PMC: 3129335. DOI: 10.1053/j.gastro.2010.10.049. View

18.

Imai K, Beppu T, Chikamoto A, Doi K, Okabe H, Hayashi H . Comparison between hepatic resection and radiofrequency ablation as first-line treatment for solitary small-sized hepatocellular carcinoma of 3 cm or less. Hepatol Res. 2013; 43(8):853-64. DOI: 10.1111/hepr.12035. View

19.

Yao F, Kerlan Jr R, Hirose R, Davern 3rd T, Bass N, Feng S . Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis. Hepatology. 2008; 48(3):819-27. PMC: 4142499. DOI: 10.1002/hep.22412. View

20.

Otto G, Herber S, Heise M, Lohse A, Monch C, Bittinger F . Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma. Liver Transpl. 2006; 12(8):1260-7. DOI: 10.1002/lt.20837. View